Insider Transactions in Q2 2022 at Illumina, Inc. (ILMN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
250
-0.59%
|
$53,500
$214.85 P/Share
|
|
May 26
2022
|
Frances Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+8.63%
|
-
|
|
May 26
2022
|
Robert S Epstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+13.86%
|
-
|
|
May 26
2022
|
Scott Gottlieb Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+26.2%
|
-
|
|
May 26
2022
|
Gary S Guthart Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+12.73%
|
-
|
|
May 26
2022
|
Philip W Schiller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+9.2%
|
-
|
|
May 26
2022
|
John Wendell Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+10.81%
|
-
|
|
May 26
2022
|
Caroline Dorsa Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+11.61%
|
-
|
|
May 26
2022
|
Susan E Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+15.98%
|
-
|
|
May 25
2022
|
Caroline Dorsa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-4.14%
|
$85,184
$242.4 P/Share
|
|
May 25
2022
|
Susan E Siegel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-6.29%
|
$85,184
$242.4 P/Share
|
|
May 05
2022
|
John Edward Frank Chief Public Affairs Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,714
+50.0%
|
-
|
|
May 05
2022
|
Jose Torres VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
69
-3.8%
|
$20,079
$291.72 P/Share
|
|
Apr 28
2022
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Indirect |
368
-4.72%
|
$110,400
$300.13 P/Share
|
|
Apr 12
2022
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,474
-5.0%
|
$858,478
$347.54 P/Share
|
|
Apr 06
2022
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,988
-25.61%
|
$715,680
$360.01 P/Share
|
|
Apr 05
2022
|
Carissa Rollins SVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+46.61%
|
-
|
|
Apr 05
2022
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-1.66%
|
$47,553
$363.84 P/Share
|
|
Apr 05
2022
|
Kevin Carl Pegels Chief of Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.78%
|
$45,375
$363.84 P/Share
|